Erythropoietin Effects After Traumatic Brain Injury

Withdrawn before enrolling · Phase 2/Phase 3

Conditions studied: Traumatic Brain Injury

In brief

To determine if the early administration of erythropoietin to patients sustaining traumatic brain injury will reduce secondary brain injury.

Key facts

Study ID

NCT00260052

Run by

Medical College of Wisconsin

People needed

0

Starts

2003-07-01

Expected to finish

2010-01-01

Last updated by the study team

2015-08-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 17, Head CT shows intracranial hemorrhage < 6 hours after injury, GCS<13 consented

You may not qualify if…

• nonsurvivable injuries for more then 48 hours, CPR in the field, patients already on erythropoietin

Where it is running

• Froedtert Hospital — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.